Hot Pursuit     20-Apr-22
Alembic Pharma rises after receiving tentative approval for anti anginal drug
Alembic Pharmaceuticals gained 1.76% to Rs 761.95 after the drug maker received tentative approval from the US Food & Drug Administration (USFDA) for ivabradine tablets.
Ivabradine Tablets are indicated to reduce the risk of worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction. The tablets are also indicated for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) in pediatric patients aged 6 months and older, who are in sinus rhythm with an elevated heart rate

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug, Corlanor Tablets of Amgen Inc. According to IQVIA, ivabradine tablets have an estimated market size of $102 million for twelve months ending December 2021.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world.

On a consolidated basis, the company reported a 39.7% fall in net profit to Rs 176.42 crore on a 3.2% fall in net sales to Rs 1,271.7 crore in Q3 FY22 over Q3 FY21.

Previous News
  Alembic Pharmaceuticals receives USFDA approval for Doxycycline Capsules
 ( Corporate News - 28-Jun-24   13:38 )
  Alembic Pharm gets US FDA approvals for five products in Q1 FY24
 ( Hot Pursuit - 03-Jul-23   09:54 )
  Alembic receives final approval for Fluorouracil Injection
 ( Corporate News - 06-Mar-23   11:32 )
  Alembic Pharmaceuticals announces board meeting date
 ( Corporate News - 19-Jan-24   14:13 )
  Alembic Pharmaceuticals receives multiple product approvals from USFDA
 ( Corporate News - 03-Jul-23   09:11 )
  Alembic Pharma gains on USFDA nod for Fluorouracil injection
 ( Hot Pursuit - 06-Mar-23   11:13 )
  Alembic Pharma Q4 PAT tumbles 86% YoY to Rs 35 cr
 ( Hot Pursuit - 03-May-22   13:38 )
  Alembic Pharma gets USFDA nod for Doxycycline Capsules
 ( Hot Pursuit - 28-Jun-24   12:20 )
  Alembic Pharma receives final approval for anti fungal drug
 ( Hot Pursuit - 08-Mar-22   11:36 )
  Alembic Pharmaceuticals Ltd gains for third straight session
 ( Hot Pursuit - 13-May-22   13:05 )
  Alembic Pharmaceuticals to table results
 ( Corporate News - 24-Apr-23   17:42 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top